ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $236,000 | -75.9% | 1,019,288 | -38.3% | 11.87% | +15728.0% |
Q4 2021 | $978,000 | -67.5% | 1,651,357 | -50.4% | 0.08% | -68.8% |
Q3 2021 | $3,005,000 | -30.6% | 3,330,373 | 0.0% | 0.24% | -39.8% |
Q2 2021 | $4,329,000 | -6.5% | 3,330,373 | 0.0% | 0.40% | +7.5% |
Q1 2021 | $4,629,000 | +8.6% | 3,330,373 | 0.0% | 0.37% | +13.1% |
Q4 2020 | $4,263,000 | -13.5% | 3,330,373 | 0.0% | 0.33% | -26.0% |
Q3 2020 | $4,929,000 | -6.3% | 3,330,373 | 0.0% | 0.44% | -4.1% |
Q2 2020 | $5,262,000 | +64.2% | 3,330,373 | 0.0% | 0.46% | +27.3% |
Q1 2020 | $3,205,000 | -64.7% | 3,330,373 | 0.0% | 0.36% | -76.2% |
Q4 2019 | $9,092,000 | -30.7% | 3,330,373 | 0.0% | 1.52% | -62.8% |
Q3 2019 | $13,122,000 | -3.2% | 3,330,373 | 0.0% | 4.10% | +18.1% |
Q2 2019 | $13,555,000 | -42.0% | 3,330,373 | 0.0% | 3.47% | -38.3% |
Q1 2019 | $23,379,000 | +28.8% | 3,330,373 | 0.0% | 5.63% | +20.2% |
Q4 2018 | $18,151,000 | -49.3% | 3,330,373 | 0.0% | 4.68% | -28.5% |
Q3 2018 | $35,768,000 | -17.6% | 3,330,373 | 0.0% | 6.55% | -27.1% |
Q2 2018 | $43,395,000 | +18.2% | 3,330,373 | 0.0% | 8.99% | +47.6% |
Q1 2018 | $36,701,000 | +9.5% | 3,330,373 | 0.0% | 6.09% | +12.1% |
Q4 2017 | $33,504,000 | – | 3,330,373 | – | 5.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $11,359,000 | 18.32% |
Deer VII & Co. Ltd. | 2,263,365 | $9,212,000 | 8.07% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $13,555,000 | 3.47% |
Partner Investment Management, L.P. | 287,851 | $1,172,000 | 1.24% |
SPHERA FUNDS MANAGEMENT LTD. | 491,193 | $1,999,000 | 0.27% |
PFM Health Sciences, LP | 788,958 | $3,211,000 | 0.06% |
Perceptive Advisors | 132,300 | $538,000 | 0.01% |
Fosun International Ltd | 29,877 | $124,000 | 0.01% |
WEDBUSH SECURITIES INC | 15,400 | $63,000 | 0.01% |
Paloma Partners Management Co | 52,100 | $212,000 | 0.00% |